Deutsche Bank cuts Axsome Therapeutics target price to $267 from $280
AXSM•Deutsche Bank cut its target price for Axsome Therapeutics to $267 from $280.
Related News
First United elects Steven Stuck, Shawn Bender, Nina Beitzel to board
FUNC•
Apyx Medical reports Renuvion study shows increased elastin, reduced inflammation at 180 days
APYX•
Lantern Pharma prices private placement warrants to buy 3,669,725 shares at $1.09 each
LTRN•
Nordic power forward prices fall after recent gains, tracking weaker related markets
UNG•
Weight Watchers partners with Google Health Enterprise to add Fitbit, AI insights to employer weight programs
WW•